CYP 1.82% 27.0¢ cynata therapeutics limited

Takeover in 2019? Price?, page-77

  1. 1,070 Posts.
    lightbulb Created with Sketch. 546

    Why do we have to choose?

    FUJI can take on both, if they haven't taken us out already.


    Why would FUJIFILM spend money on a clinical trial, knowing that Australia's peak funding body for medical research will most likely fund it? FUJIFILM probably played the waiting game to see if our application to the NHMRC was successful. The beauty of this is that we're not giving away the rights to OA and it's also non-dilutive.


    So it's a:

    WIN for CYNATA

    WIN for FUJIFILM

    WIN for SHAREHOLDERS

 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.